Literature DB >> 2149023

Testicular function after chemotherapy for osteosarcoma.

M A Siimes1, I Elomaa, A Koskimies.   

Abstract

Testicular volume, sperm count and four hormones were measured in 18 patients 1-13 years after chemotherapy for osteosarcoma. The testicles were small in 13 patients. 17 patients gave semen samples: 10 were azoospermic and 2 were oligozoospermic. Testicular volume and sperm count were possibly associated with the type of chemotherapy. Of the 7 patients who had received cisplatin-containing chemotherapy, 6 had small testes and azoospermia; 1 was oligozoospermic with normal-sized testes. In 3 of the 11 patients whose chemotherapy had not included cisplatin, testicular size and sperm count were normal.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2149023     DOI: 10.1016/0277-5379(90)90623-2

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  4 in total

1.  Effect of methotrexate on male fertility.

Authors:  Amy E French; Gideon Koren
Journal:  Can Fam Physician       Date:  2003-05       Impact factor: 3.275

2.  Fertility following treatment of high-grade malignant bone and soft tissue tumors in young adults.

Authors:  Manabu Hoshi; Masatsugu Takami; Makoto Ieguchi; Masanari Aono; Jun Takada; Naoto Oebisu; Tadashi Iwai; Hiroaki Nakamura
Journal:  Mol Clin Oncol       Date:  2014-12-03

3.  Ghrelin Prevents Cisplatin-Induced Testicular Damage by Facilitating Repair of DNA Double Strand Breaks Through Activation of p53 in Mice.

Authors:  Jose M Garcia; Ji-an Chen; Bobby Guillory; Lawrence A Donehower; Roy G Smith; Dolores J Lamb
Journal:  Biol Reprod       Date:  2015-05-27       Impact factor: 4.285

4.  Marriage and fertility in long-term survivors of childhood, adolescent and young adult (AYA) high-grade sarcoma.

Authors:  Tsukasa Yonemoto; Miyako Takahashi; Mitsue Maru; Akiko Tomioka; Masahiro Saito; Yuko Araki; Makiko Tazaki; Miyako Tsuchiya; Shintaro Iwata; Hiroto Kamoda; Takeshi Ishii
Journal:  Int J Clin Oncol       Date:  2016-01-20       Impact factor: 3.402

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.